- Home
- MOS vs ASND Comparison
MOS vs ASND Comparison
Compare MOS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOS | ASND |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 13.2B |
| IPO Year | 2004 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MOS | ASND |
|---|---|---|
| Price | $27.36 | $226.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 16 |
| Target Price | $33.69 | ★ $268.19 |
| AVG Volume (30 Days) | ★ 7.5M | 681.1K |
| Earning Date | 02-24-2026 | 02-17-2026 |
| Dividend Yield | ★ 3.20% | N/A |
| EPS Growth | ★ 235.95 | N/A |
| EPS | ★ 3.87 | N/A |
| Revenue | ★ $11,894,600,000.00 | $758,592,045.00 |
| Revenue This Year | $10.82 | $99.39 |
| Revenue Next Year | $3.52 | $84.12 |
| P/E Ratio | $7.11 | ★ N/A |
| Revenue Growth | 3.83 | ★ 97.46 |
| 52 Week Low | $22.36 | $118.03 |
| 52 Week High | $38.23 | $242.00 |
Technical Indicators
Market Signals| Indicator | MOS | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 55.42 | 55.48 |
| Support Level | $25.85 | $220.53 |
| Resistance Level | $29.07 | $242.00 |
| Average True Range (ATR) | 0.96 | 11.96 |
| MACD | 0.04 | 0.74 |
| Stochastic Oscillator | 53.23 | 69.12 |
Price Performance
Historical ComparisonAbout MOS Mosaic Company (The)
Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida and Peru and potash mines in Saskatchewan and New Mexico. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.